FMR LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:49 am Sale | 2025-09-30 | 13G | Teva Pharmaceutical Industries Limited TEVA | FMR LLC | 24,641,361 2.100% | -33,494,255 (-57.61%) | Filing |
| 2025-08-06 12:14 pm Sale | 2025-06-30 | 13G | Teva Pharmaceutical Industries Limited TEVA | FMR LLC | 58,135,616 5.100% | -23,847,612 (-29.09%) | Filing |
| 2025-02-12 09:22 am Purchase | 2024-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA | FMR LLC | 81,983,229 7.200% | 19,242,467 (+30.67%) | Filing |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Teva Pharmaceutical Industries Limited TEVA | FMR LLC | 62,740,762 5.537% | 33,877,274 (+117.37%) | Filing |